EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, AItheNutrigene Co's enterprise value is ₩30,751 Mil.
AItheNutrigene Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩9,147 Mil. Therefore, AItheNutrigene Co's EV-to-Revenue for today is 3.36.
The historical rank and industry rank for AItheNutrigene Co's EV-to-Revenue or its related term are showing as below:
XKRX:311960'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.11 Med: 4.71 Max: 7.39
Current: 3.37
During the past 4 years, the highest EV-to-Revenue of AItheNutrigene Co was 7.39. The lowest was 3.11. And the median was 4.71.
XKRX:311960's EV-to-Revenue is ranked worse than 52.66% of 826
companies
in the Medical Devices & Instruments industry
Industry Median: 3.065
vs XKRX:311960: 3.37
As of today (2024-06-09), AItheNutrigene Co's stock price is ₩9640.00.
AItheNutrigene Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,033.83. Therefore, AItheNutrigene Co's PS Ratio for today is 3.18.
AItheNutrigene Co EV-to-Revenue Historical Data
The historical data trend for AItheNutrigene Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
AItheNutrigene Co EV-to-Revenue Chart
AItheNutrigene Co Annual Data
Trend
Dec20
Dec21
Dec22
Dec23
EV-to-Revenue
-
-
7.56
4.34
AItheNutrigene Co Semi-Annual Data
Dec20
Dec21
Dec22
Dec23
EV-to-Revenue
-
-
7.56
4.34
Competitive Comparison of AItheNutrigene Co's EV-to-Revenue
For the Medical Devices subindustry, AItheNutrigene Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AItheNutrigene Co's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AItheNutrigene Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where AItheNutrigene Co's EV-to-Revenue falls into.
AItheNutrigene Co's current Enterprise Value is ₩30,751 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AItheNutrigene Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩9,147 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AItheNutrigene Co (XKRX:311960) EV-to-Revenue Explanation
AItheNutrigene Co's share price for today is ₩9640.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,033.83.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AItheNutrigene Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of AItheNutrigene Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
AItheNutrigene Co (XKRX:311960) Business Description
AItheNutriGene Co engages in developing a test-detection solution in order to check out the early detection of various diseases. The company offers molecular diagnostic technology, nutrition therapy customized according to an individual's genomics and AI bio, enabling patients and medical practitioners with tests and accurate diagnoses to prevent diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:311960 has been successfully added to your